This weekend, while speaking at the Liberty Forum of Silicon Valley, I was asked a question about the status of the development of an influenza/COVID-19 mRNA vaccine.
A quick search on clinicaltrials.gov (which is a government website where clinical trials are registered), found the following combined influenza/COVID-19 clinical trial, which is currently recruiting:
A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1073 (COVID-19/Influenza) Vaccine in Adults 18 to 75 Years Old
This is a phase 1 and 2 combined randomized clinical trial which anticipates enrollment of 1,050 participants.
Today, a reader sent me a link to the article below, which clearly shows that the pre-clinical phase of these combination vaccines has been concluded and APPROVED by the FDA. Enrollment for the clinical trials is about to begin.
Clinical trials for ‘entirely new’ mRNA flu vaccines launching soon. Will they work better?
Based on COVID-19 ‘messenger’ RNA or mRNA vaccines, th...
Full Access
Included:
-
Access to All Articles.
-
One Plan. No Tiers.
-
No Ads.
-
Cancel anytime.
